Skip Navigation

Phase III Study of Navitoclax Plus Ruxolitinib Versus Ruxolitinib Compound ABT-263

Brief Summary

Type:
Myelofibrosis

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT04472598

Study #:
Study00146299

Start Date:
Jan 26, 2021

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04472598

View Complete Trial Details & Eligibility at ClinicalTrials.gov